分析丹红注射液联合奥拉西坦治疗脑梗塞的疗效

Therapeutic Effect of Danhong Injection Combined with Olaxetam on Cerebral Infarction

目的:分析丹红注射液与奥拉西坦联合治疗脑梗塞的临床疗效。方法:随机在某院2015年11月~2016年11月收治的脑梗塞患者中选取112例为研究对象,根据平均分配将其分为对照组与研究组,给予对照组患者丹红注射液治疗,而研究组患者则在丹红治疗的基础上施加奥拉西坦进行联合治疗,对两组患者的治疗效果进行观察与比较。结果:研究组与对照组两组患者治疗后的临床治疗总有效率分别为98.21%与94.64%,两组在治疗总有效率上比较无明显差异(P>0.05);但研究组的治愈率39.29%与显效率42.86%皆明显高于对照组的治愈率28.57%与显效率32.14%(P<0.05);同时治疗后研究组患者的NIM评分(14.51±2.41)分也明显低于对照组患者的(23.64±3.11)分(P<0.05)。结论:应用丹红注射液与奥拉西坦联合治疗脑梗塞患者,对于促进患者神经功能的恢复,提高临床治疗效果具有明显作用,临床应用价值较高。

Objective：To analyze the clinical effect of Danhong injection combined with oxiracetam in the treatment of cerebral infarction.Methods：112 patients with cerebral infarction admitted in a hospital from November 2015 to November 2016 were randomly selected and divided into control group and study group according to their average distribution.The patients in the control group were treated with Danhong injection,while the patients in the study group were treated with oxiracetam on the basis of control group.The therapeutic effects of the two groups were observed and compared.Results：The total effective rates of the two groups were 98.21% and 94.64%,respectively.There was no significant difference in the total effective rate between the two groups（P〈0.05）;The cure rate and effective rate of the study group were 39.29% and42.86%respectively,which were significantly higher than those of the control group（28.57% and 32.14%,P〈0.05）.At the same time,the NIM score of the study group（14.51±2.41）was significantly lower than that of the control group（23.64±3.11）（P〈0.05）.Conclusion：The combination of Danhong injection and olaxetam in the treatment of patients with cerebral infarction has a significant effect on promoting the recovery of neurological function and improving the effect of clinical treatment,which has higher clinical value.